Key result
Ventricular noncompaction management lacks specific therapies and focuses primarily on controlling symptoms and disease progression.
Why the study?
Specific treatments for most patients with noncompaction of ventricular myocardium are not currently available, necessitating a critical reexamination of appropriate therapeutic strategies.
Treatment for noncompaction of ventricular myocardium currently relies on standard therapies for heart failure, arrhythmias, and anticoagulation, as specific targeted treatments are lacking.
Answers are grounded in this paper and cite their sources.
Supports supportive management only; leaves open targeted therapy development for noncompaction.
AIMS: Critically reexamine and place in perspective the most appropriate therapeutic strategies for patients noncompaction of ventricular myocardium. RESULTS: Specific treatments are not available for the majority of patients with noncompaction of ventricular myocardium currently. Treatment of patients with noncompaction of ventricular myocardium could be similar to patients with other cardiomyopathies, especially dialated cardiomyopathy, and therefore, the primary aims of treatment are to control symptoms, disease progression, and complications, which should include appropriate treatment for heart failure, management of arrhythmias, and oral anticoagulation to prevent systemic emboli. CONCLUSION: Among the many challenges facing clinicians treating patients with noncompaction of ventricular myocardium are the detection of early disease, the identification of the predominant mechanism of left ventricular dysfunction, and the development of treatments that target the initiating mechanism of disease. Nevertheless, there have been major advances in our understanding of the genetic basis of noncompaction of ventricular myocardium, and recent advances in the drug therapy and nondrug therapy of noncompaction of ventricular myocardium have substantially improved the outlook for many patients. The rapid pace of current research and the development of new treatments for the management of both early and late disease augur well for the future.
No takes yet. Share an insight, caveat, or question.
Ze–Zhou Song (2010) conducted a review in Noncompaction of ventricular myocardium. Therapeutic strategies was evaluated. Therapeutic strategies for noncompaction of ventricular myocardium currently lack specific treatments and primarily focus on controlling symptoms, disease progression, and complications.
Synapse has enriched 10 related papers. Consider them for comparative context: